Logo

2017 Vol.35, N°4 - Suppl.106 - Table of contents

Scleroderma 2017Title: Scleroderma 2017

10th Annual Supplement on Systemic Sclerosis

Guest Editor: S. Bombardieri

Purchase all articles

PageArticle - [Author(s)]PDFAbs.
One year in review

CER10809
2017,35,4,Suppl.106
Pg. 0003-0020

One year in review 2017: systemic sclerosis
S. Barsotti, C. Bruni, M. Orlandi, A. Della Rossa, E. Marasco, V. Codullo, S. Guiducci › Free to View
Rheumatology ArticleRheumatology Abstract
Etiopathogenesis

CER9845
2017,35,4,Suppl.106
Pg. 0021-0030

Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts
P. Wermuth, S. Piera-Velazquez, S. Jimenez › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER9910
2017,35,4,Suppl.106
Pg. 0031-0034

Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis
E. Marou, C. Liaskos, G. Efthymiou, E. Dardiotis, A. Daponte, T. Scheper, W. Meyer, G. Hadjigeorgiou, D. Bogdanos, L. Sakkas
Rheumatology ArticleRheumatology Abstract
 

CER9967
2017,35,4,Suppl.106
Pg. 0035-0039

Dabigatran aggravates topoisomerase I peptide-loaded dendritic cells-induced lung and skin fibrosis
H. Mehta, S. Mashiko, P. Goulet, J. Desjardins, G. Pérez, M. Koenig, J. Senécal, M. Sarfati
Rheumatology ArticleRheumatology Abstract
Clinical aspects

CER9503
2017,35,4,Suppl.106
Pg. 0040-0047

Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)
M. Rubio-Rivas, C. Simeón-Aznar, C. Velasco, B. Marí-Alfonso, G. Espinosa, X. Corbella, D. Colunga-Argüelles, M. Egurbide-Arberas, N. Ortego-Centeno, J. Vargas-Hitos, M. Freire, J. Ríos-Blanco, L. Trapiella-Martínez, M. Rodríguez-Carballeira, V. Fonollosa-Pla; on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
Rheumatology ArticleRheumatology Abstract
 

CER9777
2017,35,4,Suppl.106
Pg. 0048-0055

Three-year trajectories of disability and fatigue in systemic sclerosis: a cohort study
L. Willems, L. Kwakkenbos, M. Vonk, F. van den Hoogen, T. Vliet Vlieland, C. van den Ende
Rheumatology ArticleRheumatology Abstract
 

CER9924
2017,35,4,Suppl.106
Pg. 0056-0060

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis
G. Li, J. Adachi, J. Cheng, L. Thabane, M. Hudson, M. Fritzler, S. Lorenzi, M. Baron, M. Larché; for the Canadian Scleroderma Research Group.
Rheumatology ArticleRheumatology Abstract
 

CER10142
2017,35,4,Suppl.106
Pg. 0061-0070

The presence of small joint contractures is a risk factor for survival in 439 patients with systemic sclerosis.
G. Nagy, T. Minier, C. Varjú, R. Faludi, K. Kovács, V. Lóránd, V. Hermann, L. Czirják, G. Kumánovics
Rheumatology ArticleRheumatology Abstract
 

CER10201
2017,35,4,Suppl.106
Pg. 0071-0074

Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease
A. Shah, A. Rosen, L. Hummers, B. May, A. Kaushiva, R. Roden, D. Armstrong, F. Wigley, L. Casciola-Rosen, K. Visvanathan › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER10460
2017,35,4,Suppl.106
Pg. 0075-0081

Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
O. Distler, K. Brown, J. Distler, S. Assassi, T. Maher, V. Cottin, J. Varga, C. Coeck, M. Gahlemann, W. Sauter, H. Schmidt, K. Highland; on behalf of the SENSCIS™ trial investigators
Rheumatology ArticleRheumatology Abstract
 

CER10368
2017,35,4,Suppl.106
Pg. 0082-0085

Severe oesophageal disease and its associations with systemic sclerosis
G. Karamanolis, K. Denaxas, S. Panopoulos, K. Bournia, A. Zorbala, D. Kamberoglou, D. Schizas, S. Ladas, P. Sfikakis
Rheumatology ArticleRheumatology Abstract
 

CER10649
2017,35,4,Suppl.106
Pg. 0086-0088

Oesophageal disease in systemic sclerosis: does heritability play a role?
T. Frech, L. Fakoya, A. Gawron, J. Wong, M. Scholand, A. Sawitzke, K. Peterson
Rheumatology ArticleRheumatology Abstract
 

CER10557
2017,35,4,Suppl.106
Pg. 0089-0097

Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review
M. Freire, A. Rivera, B. Sopeña, C. Tolosa Vilella, A. Guillén-Del Castillo, D. Colunga Argüelles, J. Callejas Rubio, M. Rubio Rivas, L. Trapiella Martínez, J. Todolí Parra, M. Rodríguez Carballeira, N. Iniesta Arandia, F. García Hernández, M. Egurbide Arberas, L. Sáez Comet, J. Vargas Hitos, J. Ríos Blanco, A. Marín Ballvé, X. Pla Salas, A. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, C. Simeón Aznar; on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS) › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER10639
2017,35,4,Suppl.106
Pg. 0098-0105

Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis
N. Iniesta Arandia, C. Simeón-Aznar, A. Guillén del Castillo, D. Colunga Argüelles, M. Rubio-Rivas, L. Trapiella Martínez, F. García Hernández, L. Sáez Comet, M. Egurbide Arberas, N. Ortego-Centeno, M. Freire, B. Marí Alfonso, J. Vargas Hitos, J. Ríos Blanco, J. Todolí Parra, M. Rodríguez-Carballeira, A. Marín Ballvé, A. Chamorro Fernández, X. Pla Salas, A. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, G. Espinosa; on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS). › Free to View
Rheumatology ArticleRheumatology Abstract
Diagnosis

CER9389
2017,35,4,Suppl.106
Pg. 0106-0113

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry
L. Chung, R. Fairchild, D. Furst, S. Li, F. Alkassab, M. Bolster, M. Csuka, C. Derk, R. Domsic, A. Fischer, T. Frech, M. Gomberg-Maitland, J. Gordon, M. Hinchcliff, V. Hsu, L. Hummers, D. Khanna, T. Medsger, J. Molitor, I. Preston, E. Schiopu, L. Shapiro, F. Hant, R. Silver, R. Simms, J. Varga, V. Steen, R. Zamanian
Rheumatology ArticleRheumatology Abstract
 

CER9677
2017,35,4,Suppl.106
Pg. 0114-0121

Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
P. Carreira, L. Carmona, B. Joven, E. Loza, J. Andreu, G. Riemekasten, S. Vettori, Y. Allanore, A. Balbir-Gurman, P. Airò, U. Walker, N. Damjanov, L. Ananieva, S. Rednic, L. Czirják, O. Distler, D. Farge, R. Hesselstrand, A. Corrado, P. Caramaschi, M. Tikly, M. Matucci-Cerinic; and EUSTAR co-authors
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER9886
2017,35,4,Suppl.106
Pg. 0122-0129

Six-minute walk test in or out in evaluation of systemic sclerosis patients?
E. Vandecasteele, K. Thevissen, K. Melsens, F. De Keyser, M. De Pauw, E. Deschepper, S. Decuman, Y. Piette, G. Brusselle, V. Smith
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER10311
2017,35,4,Suppl.106
Pg. 0130-0137

Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis
K. Morrisroe, W. Stevens, M. Huq, J. Sahhar, G. Ngian, J. Zochling, J. Roddy, S. Proudman, M. Nikpour; the Australian Scleroderma Interest Group (ASIG)
Rheumatology ArticleRheumatology Abstract
 

CER10355
2017,35,4,Suppl.106
Pg. 0138-0143

The use of hand perfusion scintigraphy to assess Raynaud’s phenomenon associated with hand-arm vibration syndrome
K. Lee, H. Chung, S. Lee, H. Kim
Rheumatology ArticleRheumatology Abstract
 

CER10174
2017,35,4,Suppl.106
Pg. 0144-0150

Resistin: a possible biomarker of organ involvement in systemic sclerosis patients?
K. Sawicka, M. Michalska-Jakubus, M. Kowal, E. Potembska, D. Krasowska
Rheumatology ArticleRheumatology Abstract
Treatment

CER10087
2017,35,4,Suppl.106
Pg. 0151-0158

Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study
F. Andrigueti, P. Ebbing, M. Arismendi, C. Kayser › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER10068
2017,35,4,Suppl.106
Pg. 0159-0166

Efficacy of intensive hand physical therapy in patients with systemic sclerosis
J. Horváth, Z. Bálint, E. Szép, A. Deiszinger, T. Minier, N. Farkas, E. Török, É. Horváthné Papp, D. Komjáti, Z. Mándó, L. Czirják, C. Varjú
Rheumatology ArticleRheumatology Abstract
 

CER10403
2017,35,4,Suppl.106
Pg. 0167-0172

Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis
D. Machin, H. Clifton, R. Richardson, D. Wray, A. Donato, T. Frech
Rheumatology ArticleRheumatology Abstract
 

CER10391
2017,35,4,Suppl.106
Pg. 0173-0178

A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA)
P. Fraticelli, G. Martino, M. Murri, M. Mattioli, A. Gabrielli › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER10476
2017,35,4,Suppl.106
Pg. 0179-0183

Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study
M. Colaci, F. Lumetti, D. Giuggioli, S. Guiducci, S. Bellando-Randone, G. Fiori, M. Matucci-Cerinic, C. Ferri
Rheumatology ArticleRheumatology Abstract
Review

CER9760
2017,35,4,Suppl.106
Pg. 0184-0192

Patient participation in patient-reported outcome instrument development in systemic sclerosis
J. Pauling, T. Frech, R. Domsic, M. Hudson › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER9691
2017,35,4,Suppl.106
Pg. 0193-0197

Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience
A. Antonelli, P. Fallahi, F. Di Bari, D. Giuggioli, S. Ferrari, C. Ferri
Rheumatology ArticleRheumatology Abstract
 

CER10242
2017,35,4,Suppl.106
Pg. 0198-0207

Autologous stem cell transplantation in systemic sclerosis: a systematic review
L. Host, M. Nikpour, A. Calderone, P. Cannell, J. Roddy › Free to View
Rheumatology ArticleRheumatology Abstract
Case Report

CER10014
2017,35,4,Suppl.106
Pg. 0208-0210

Treatment of psoriasis with ustekinumab improved skin tightening in systemic sclerosis
A. Ichihara, M. Jinnin, H. Ihn
Rheumatology ArticleRheumatology Abstract
Paediatric Rheumatology

CER10478
2017,35,4,Suppl.106
Pg. 0211-0213

Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?
G. Martini, S. Campus, R. Bernd, G. Boscarol, A. Meneghel, F. Zulian
Rheumatology ArticleRheumatology Abstract
Letters to the Editor

CER9881
2017,35,4,Suppl.106
Pg. 0214-0215

Successful treatment of a refractory dysbiotic intestinal pseudo-obstruction in a patient with systemic sclerosis-polymyositis overlap syndrome by intravenous immunoglobulin administration possibly related to gut flora normalisation
R. Kamei, T. Yamaoka, K. Ikinaga, H. Murota, K. Shimizu, I. Katayama
Rheumatology ArticleRheumatology Abstract
 

CER10080
2017,35,4,Suppl.106
Pg. 0216

Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors
E. De Langhe, J. Lenaerts, P. Demaerel, R. Lemmens
Rheumatology ArticleRheumatology Abstract
 

CER10380
2017,35,4,Suppl.106
Pg. 0217

Reply to: Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors
F. Wegner, U. Müller-Ladner, F. Meier
Rheumatology ArticleRheumatology Abstract
 

CER9741
2017,35,4,Suppl.106
Pg. 0218-0219

A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials?
M. Hughes, T. Moore, J. Manning, G. Dinsdale, A. Herrick, A. Murray
Rheumatology ArticleRheumatology Abstract
 

CER10306
2017,35,4,Suppl.106
Pg. 0220

Serum thyroxine levels are associated with increased systolic pulmonary arterial pressure in systemic sclerosis
G. Bagnato, R. Ruggeri, R. Certo, M. Cusmà Piccione, S. Carerj, W. Roberts
Rheumatology ArticleRheumatology Abstract
 

CER10342
2017,35,4,Suppl.106
Pg. 0221-0222

Significance of pentraxin-3 in patients with juvenile scleroderma
A. Adrovic, S. Sahin, K. Barut, S. Durmus, H. Uzun, O. Kasapcopur
Rheumatology ArticleRheumatology Abstract
 

CER10737
2017,35,4,Suppl.106
Pg. 0223-0224

Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?
C. Chighizola, E. Raschi, D. Privitera, A. Luppino, C. Artusi, T. Schioppo, C. Mastaglio, F. Ingegnoli, M. Borghi, P. Meroni
Rheumatology ArticleRheumatology Abstract